Proposals for the rheumatological use of JAK inhibitors

被引：0

作者：

Francesco Ciccia

Roberto Caporali

机构：

[1] University della Campania,

[2] Department of Precision Medicine,undefined

[3] University of Milan and ASST Gaetano Pini-CTO,undefined

来源：

Nature Reviews Rheumatology | 2024年 / 20卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Janus kinase inhibitors have therapeutic potential for patients with immune-mediated inflammatory diseases, and evidence of greater risks of cardiovascular disease and malignancy than with TNF inhibitors should be carefully considered before recommendations against their use are made. Assessment of the risk–benefit ratios in these patients can instead guide clinical decision-making.

引用

页码：65 / 66

页数：1

共 50 条

[21] Macrocyclic inhibitors of JAK
Wayland, Brian R.
Douty, Brent
Yue, Eddy
Combs, Andrew
Liao, Boshan
Li, Yanlong
Margulis, Alexander
Gallagher, Karen
Covington, Maryanne
Wynn, Rich
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
[22] JAK inhibitors in autoinflammation
Hoffman, Hal M.
Broderick, Lori
JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (07): : 2760 - 2762
[23] JAK Inhibitors in Rheumatology
Witte, Torsten
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (11) : 748 - 752
[24] Selective JAK inhibitors
Dymock, Brian W.
Yang, Eugene Guorong
Chu-Farseeva, Yuyi
Yao, Lianbin
FUTURE MEDICINAL CHEMISTRY, 2014, 6 (12) : 1439 - 1471
[25] New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib
Marcuzzi, Annalisa
Rimondi, Erika
Melloni, Elisabetta
Gonelli, Arianna
Grasso, Antonio Giacomo
Barbi, Egidio
Maximova, Natalia
PHARMACEUTICALS, 2022, 15 (03)
[26] JAK inhibitors in patients with atopic dermatitis: systematic review on the use of Abrocitinib
Nascimento, Paloma Gargalho
Argote, Javier Gonzalez
REVISTA CUBANA DE REUMATOLOGIA, 2023, 25 (02):
[27] An Update on JAK Inhibitors
Musumeci, Francesca
Greco, Chiara
Giacchello, Ilaria
Fallacara, Anna Lucia
Ibrahim, Munjed M.
Grossi, Giancarlo
Brullo, Chiara
Schenone, Silvia
CURRENT MEDICINAL CHEMISTRY, 2019, 26 (10) : 1806 - 1832
[28] Rheumatological adverse events secondary to immune checkpoint inhibitors
Garbarino, Maria Cecilia
Manzano, Natalia
Messina, Osvaldo
Zylberman, Marcelo
REUMATOLOGIA CLINICA, 2023, 19 (04): : 215 - 222
[29] Encouraging appropriate use of proton pump inhibitors: existing initiatives and proposals for the future
Mari, Amir
Marabotto, Elisa
Ribolsi, Mentore
Zingone, Fabiana
Barberio, Brigida
Savarino, Vincenzo
Savarino, Edoardo Vincenzo
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023,
[30] Current use of analgesics for rheumatological pain
Bertin, P
EUROPEAN JOURNAL OF PAIN-LONDON, 2000, 4 : 9 - 13

← 1 2 3 4 5 →